A detailed history of Greenleaf Trust transactions in Amgen Inc stock. As of the latest transaction made, Greenleaf Trust holds 17,804 shares of AMGN stock, worth $5.74 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
17,804
Previous 17,608 1.11%
Holding current value
$5.74 Million
Previous $5.01 Million 11.11%
% of portfolio
0.05%
Previous 0.05%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$262.75 - $319.31 $51,499 - $62,584
196 Added 1.11%
17,804 $5.56 Million
Q1 2024

Apr 29, 2024

BUY
$268.87 - $324.56 $21,778 - $26,289
81 Added 0.46%
17,608 $5.01 Million
Q4 2023

Jan 31, 2024

BUY
$255.7 - $288.46 $1,789 - $2,019
7 Added 0.04%
17,527 $5.05 Million
Q3 2023

Nov 09, 2023

BUY
$218.65 - $271.46 $400,785 - $497,586
1,833 Added 11.68%
17,520 $4.71 Million
Q2 2023

Aug 09, 2023

SELL
$214.27 - $253.37 $288,407 - $341,036
-1,346 Reduced 7.9%
15,687 $3.48 Million
Q1 2023

May 11, 2023

BUY
$225.79 - $275.2 $150,376 - $183,283
666 Added 4.07%
17,033 $4.12 Million
Q4 2022

Jan 25, 2023

BUY
$229.03 - $291.01 $79,702 - $101,271
348 Added 2.17%
16,367 $4.3 Million
Q3 2022

Nov 10, 2022

SELL
$224.46 - $253.15 $70,480 - $79,489
-314 Reduced 1.92%
16,019 $3.61 Million
Q2 2022

Aug 12, 2022

BUY
$230.71 - $256.74 $5,767 - $6,418
25 Added 0.15%
16,333 $3.97 Million
Q1 2022

Apr 27, 2022

BUY
$219.27 - $242.57 $672,939 - $744,447
3,069 Added 23.18%
16,308 $3.94 Million
Q4 2021

Feb 11, 2022

SELL
$198.88 - $227.6 $406,311 - $464,986
-2,043 Reduced 13.37%
13,239 $2.98 Million
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $5,519 - $6,466
-26 Reduced 0.17%
15,282 $3.25 Million
Q2 2021

Aug 10, 2021

BUY
$233.58 - $259.14 $32,000 - $35,502
137 Added 0.9%
15,308 $3.73 Million
Q1 2021

Apr 30, 2021

BUY
$221.91 - $258.6 $375,249 - $437,292
1,691 Added 12.54%
15,171 $3.78 Million
Q4 2020

Feb 08, 2021

SELL
$216.38 - $257.67 $128,746 - $153,313
-595 Reduced 4.23%
13,480 $3.1 Million
Q3 2020

Oct 30, 2020

SELL
$234.65 - $260.95 $70,629 - $78,545
-301 Reduced 2.09%
14,075 $3.58 Million
Q2 2020

Aug 12, 2020

BUY
$197.81 - $242.74 $428,456 - $525,774
2,166 Added 17.74%
14,376 $3.39 Million
Q1 2020

Apr 29, 2020

BUY
$182.24 - $241.7 $46,471 - $61,633
255 Added 2.13%
12,210 $2.48 Million
Q4 2019

Feb 11, 2020

SELL
$189.21 - $243.2 $133,960 - $172,185
-708 Reduced 5.59%
11,955 $2.88 Million
Q3 2019

Nov 08, 2019

BUY
$174.11 - $208.62 $434,926 - $521,132
2,498 Added 24.57%
12,663 $2.45 Million
Q2 2019

Jul 24, 2019

SELL
$166.7 - $195.41 $403,914 - $473,478
-2,423 Reduced 19.25%
10,165 $1.87 Million
Q1 2019

May 08, 2019

SELL
$180.87 - $203.88 $145,781 - $164,327
-806 Reduced 6.02%
12,588 $2.39 Million
Q4 2018

Feb 07, 2019

BUY
$178.4 - $208.25 $85,988 - $100,376
482 Added 3.73%
13,394 $2.61 Million
Q3 2018

Oct 29, 2018

BUY
$185.29 - $208.89 $123,032 - $138,702
664 Added 5.42%
12,912 $2.68 Million
Q2 2018

Aug 07, 2018

BUY
$166.05 - $186.51 $162,064 - $182,033
976 Added 8.66%
12,248 $2.26 Million
Q1 2018

Apr 30, 2018

BUY
$169.43 - $198.0 $162,144 - $189,486
957 Added 9.28%
11,272 $1.92 Million
Q4 2017

Feb 08, 2018

SELL
$168.79 - $188.59 $57,219 - $63,932
-339 Reduced 3.18%
10,315 $1.79 Million
Q3 2017

Nov 13, 2017

BUY
$167.29 - $191.0 $1.78 Million - $2.03 Million
10,654
10,654 $1.99 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $173B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Greenleaf Trust Portfolio

Follow Greenleaf Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenleaf Trust, based on Form 13F filings with the SEC.

News

Stay updated on Greenleaf Trust with notifications on news.